Table 2.
|
|||||
---|---|---|---|---|---|
Total N | Margin Positive | Likelihood of Margin Positive | |||
N (%) | p value | aOR* (95% CI) | p value | ||
Pre-operative radiation | <.001 | ||||
Yes | 590 | 51(8.6) | 1.59(1.17–2.15) | 0.003 | |
No | 107660 | 4896(4.6) | 1 | ||
Pre-operative chemotherapy | <.001 | ||||
Yes | 1640 | 124(7.6) | 1.19(0.98 –1.45) | 0.08 | |
No | 107660 | 4896(4.6) | 1 | ||
Pre-operative chemoradiation | <.001 | ||||
Yes | 1653 | 151(9.1) | 1.17(0.98–1.41) | 0.09 | |
No | 107660 | 4896(4.6) | 1 |
Odds ratio adjusted for age at diagnosis, gender, race/ethnicity, insurance, median income level, urban/rural, histology, tumor grade, tumor size, primary site, T stage, N stage, Surgical type, facility type, proportion of Medicaid/Uninsured, proportion of Lung Cancer surgery, Volume of cancer surgery